Literature DB >> 8175653

Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide.

S L Hart1, A M Knight, R P Harbottle, A Mistry, H D Hunger, D F Cutler, R Williamson, C Coutelle.   

Abstract

Ligands that bind mammalian cell surface integrins with high affinity can mediate cellular internalization. We show that particles of the bacteriophage fd that display the cyclic integrin-binding peptide sequence GGCRGDMFGC in a proportion of their major coat protein subunits bind to cells and are efficiently internalized. In the displayed peptide the conformation of the RGD motif is restricted within a hairpin loop formed by a disulfide bridge between the 2 cysteine residues. Cellular internalization of phage was demonstrated by confocal and non-confocal immunofluorescence microscopy of tissue-cultured cells incubated with phage particles. The phage were contained in juxtanuclear vesicles in the same serial sections as transferrin receptor but were not colocalized with the cell surface marker alkaline phosphatase. Cell binding and internalization was inhibited by preincubation of cells with the integrin-binding peptide GRGDSP, whereas the control peptide GRGESP had no inhibitory effect. These results indicate that cyclic integrin-binding peptides can be used to target and enter cells and that it should be possible to exploit such peptides for the introduction of DNA, drugs, or other macromolecules.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175653

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Redirecting retroviral tropism by insertion of short, nondisruptive peptide ligands into envelope.

Authors:  Timothy J Gollan; Michael R Green
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 2.  Selection and characterization of cell binding and internalizing phage antibodies.

Authors:  Yu Zhou; Lequn Zhao; James D Marks
Journal:  Arch Biochem Biophys       Date:  2012-05-22       Impact factor: 4.013

3.  Evolutionary selection of new breast cancer cell-targeting peptides and phages with the cell-targeting peptides fully displayed on the major coat and their effects on actin dynamics during cell internalization.

Authors:  Gopal Abbineni; Sita Modali; Barbara Safiejko-Mroczka; Valery A Petrenko; Chuanbin Mao
Journal:  Mol Pharm       Date:  2010-08-25       Impact factor: 4.939

Review 4.  Bacteriophages and its applications: an overview.

Authors:  Sonika Sharma; Soumya Chatterjee; Sibnarayan Datta; Rishika Prasad; Dharmendra Dubey; Rajesh Kumar Prasad; Mohan G Vairale
Journal:  Folia Microbiol (Praha)       Date:  2016-10-08       Impact factor: 2.099

Review 5.  Bacteriophages and medical oncology: targeted gene therapy of cancer.

Authors:  Babak Bakhshinejad; Marzieh Karimi; Majid Sadeghizadeh
Journal:  Med Oncol       Date:  2014-07-11       Impact factor: 3.064

6.  Discovery of internalizing antibodies to tumor antigens from phage libraries.

Authors:  Yu Zhou; James D Marks
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

7.  Cloning and analysis of monkey fertilin reveals novel alpha subunit isoforms.

Authors:  A C Perry; P M Gichuhi; R Jones; L Hall
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

Review 8.  Virus-Derived Peptides for Clinical Applications.

Authors:  Mingying Yang; Kegan Sunderland; Chuanbin Mao
Journal:  Chem Rev       Date:  2017-07-19       Impact factor: 60.622

9.  Clathrin-mediated endocytosis and subsequent endo-lysosomal trafficking of adeno-associated virus/phage.

Authors:  Charlotte A Stoneham; Michael Hollinshead; Amin Hajitou
Journal:  J Biol Chem       Date:  2012-08-22       Impact factor: 5.157

Review 10.  Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.

Authors:  Mahdi Karimi; Hamed Mirshekari; Seyed Masoud Moosavi Basri; Sajad Bahrami; Mohsen Moghoofei; Michael R Hamblin
Journal:  Adv Drug Deliv Rev       Date:  2016-03-17       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.